Vitamin D Quartile | |||||||
---|---|---|---|---|---|---|---|
<20 ng/mL | 20–39 ng/mL | 40–59 ng/mL | 60 + ng/mL | Total | 25(OH)D | ||
Characteristic | No. patients (%) | No. patients (%) | No. patients (%) | No. patients (%) | No. patients (%) | Avg. ng/mL (SD) | P-value |
Gender | |||||||
Male | 105 (56) | 167 (56) | 63 (52) | 7 (32) | 342 (55) | 28 (±14) | 0.15 |
Female | 83 (44) | 129 (44) | 58 (48) | 15 (68) | 285 (45) | 30 (±17) | |
Ethnicity | <0.0001 | ||||||
Caucasian | 118 (25) | 236 (50) | 106 (22) | 16 (3) | 476 (76) | 31 (±15) | |
African American | 57 (53) | 36 (34) | 11 (10) | 3 (3) | 107 (17) | 22 (±15) | |
Hispanic | 0 (0) | 7 (44) | 0 (0) | 1 (6) | 16 (3) | 22 (±14) | |
Asian | 0 (0) | 4 (100) | 0 (0) | 0 (0) | 4 (0.6) | 30 (±6) | |
Polynesian | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 1 (0.2) | 48 (±0) | |
Other* | 5 (22) | 5 (22) | 3 (13) | 2 (9) | 23 (4) | 30 (±16) | |
Cancer Stage | 0.36 | ||||||
1B | 4 (50) | 2 (25) | 2 (25) | 0 (0) | 8 (1) | 23 (±14) | |
2A | 13 (48) | 9 (33) | 4 (4) | 1 (4) | 27 (4) | 24 (±16) | |
2B | 15 (31) | 27 (56) | 3 (6) | 3 (6) | 48 (8) | 27 (±14) | |
3 | 24 (28) | 40 (47) | 19 (22) | 3 (3) | 86 (14) | 30 (±15) | |
4 | 131(29) | 216 (48) | 92 (20) | 15 (3) | 454 (72) | 29 (±16) | |
Non-staged | 1 (25) | 2 (50) | 1 (25) | 0 (0) | 4 (1) | 28 (±11) | |
BMI (kg/m2) | 0.05 | ||||||
< 18.5 | 7 (27) | 8 (31) | 9 (35) | 2 (8) | 26 (4) | 35 (±19) | |
18.5–24.9 | 67 (25) | 126 (48) | 57 (22) | 14 (5) | 264 (42) | 31 (±17) | |
25–29.9 | 74 (36) | 98 (47) | 33 (16) | 2 (1) | 207 (33) | 26 (±13) | |
30+ | 40 (31) | 64 (49) | 22 (17) | 4 (3) | 130 (21) | 28 (±14) |